• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度非小细胞肺癌患者间变性淋巴瘤激酶重排的荧光原位杂交与免疫组织化学分析的不一致性

Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer.

作者信息

Kumar Manish, Kumar Kishore, Singh Harinder Pal, Nair Suresh, Patel Amol, Kumar Ashok, Soni Sneha

机构信息

Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India.

Department of Medical Oncology, Command Hospital Air Force, Bengaluru, Karnataka, India.

出版信息

South Asian J Cancer. 2020 Jun;9(2):109-114. doi: 10.1055/s-0040-1721191. Epub 2020 Dec 14.

DOI:10.1055/s-0040-1721191
PMID:33354554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7745737/
Abstract

This study aims to evaluate the incidence of anaplastic lymphoma kinase (ALK) mutation in nonsmall cell lung cancer (NSCLC) incorporating fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) methods and to look for any discordance.  We evaluated 101 samples obtained from an enriched cohort of NSCLCs patients from the Army Hospital Research and Referral, New Delhi, India, between November 2016 and November 2018. IHC was performed using the highly-sensitive D5F3 rabbit monoclonal primary antibody. FISH was performed with dual-color, break-apart probe (ZytoLight SPEC) on formalin-fixed, and paraffin-embedded tissue. Discordance between IHC and FISH for ALK rearrangements was evaluated. Pearson correlation coefficient ( ) was performed to identify any association of ALK presence (by IHC and FISH) with smoking brain metastasis, programmed death-ligand (PD-L1) expression, pleural effusion, and histopathological subtype.  A total of 7.92% (8/101) cases tested by IHC and 9.9% (10/101) cases tested by FISH were positive for ALK rearrangement. Of 93 ALK IHC-negative cases, 4 were ALK FISH-positive, whereas of 91 ALK FISH-negative cases, 4 were ALK IHC-positive cases. The correlation analysis demonstrated no or very weak correlation in ALK mutations by IHC or FISH with smoking, brain metastasis, PD-L1 expression, pleural effusion, and histopathological examination, except a weak positive correlation ( = 0.33) observed between brain metastasis and ALK rearrangement identified by FISH.  Our study demonstrated a somewhat similar incidence of ALK FISH-positive cases and ALK IHC-positive cases, though the incidence was numerically higher for ALK-FISH method.

摘要

本研究旨在采用荧光原位杂交(FISH)和免疫组织化学(IHC)方法评估非小细胞肺癌(NSCLC)中间变性淋巴瘤激酶(ALK)突变的发生率,并寻找两者之间的不一致性。

我们对2016年11月至2018年11月期间从印度新德里陆军医院研究与转诊中心的NSCLC患者富集队列中获取的101份样本进行了评估。使用高灵敏度的D5F3兔单克隆一抗进行免疫组织化学检测。采用双色、断裂分离探针(ZytoLight SPEC)对福尔马林固定、石蜡包埋组织进行荧光原位杂交检测。评估了免疫组织化学和荧光原位杂交检测ALK重排之间的不一致性。采用Pearson相关系数( )来确定ALK存在(通过免疫组织化学和荧光原位杂交)与吸烟、脑转移、程序性死亡配体(PD-L1)表达、胸腔积液和组织病理学亚型之间的任何关联。

通过免疫组织化学检测的病例中,共有7.92%(8/101)为ALK重排阳性,通过荧光原位杂交检测的病例中,9.9%(10/101)为ALK重排阳性。在93例免疫组织化学ALK阴性病例中,4例荧光原位杂交ALK阳性;而在91例荧光原位杂交ALK阴性病例中,4例免疫组织化学ALK阳性。相关性分析表明,免疫组织化学或荧光原位杂交检测的ALK突变与吸烟、脑转移、PD-L1表达、胸腔积液和组织病理学检查之间无或仅有非常弱的相关性,不过荧光原位杂交检测出的脑转移与ALK重排之间观察到弱正相关( = 0.33)。

我们的研究表明,ALK荧光原位杂交阳性病例和ALK免疫组织化学阳性病例的发生率有些相似,尽管荧光原位杂交法的发生率在数值上更高。

相似文献

1
Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer.印度非小细胞肺癌患者间变性淋巴瘤激酶重排的荧光原位杂交与免疫组织化学分析的不一致性
South Asian J Cancer. 2020 Jun;9(2):109-114. doi: 10.1055/s-0040-1721191. Epub 2020 Dec 14.
2
A comparative analysis of immunohistochemistry and fluorescent hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm.免疫组织化学与荧光杂交检测法在肺腺癌病例中检测间变性淋巴瘤激酶状态的比较分析:探寻一种检测算法
Indian J Cancer. 2017 Jan-Mar;54(1):148-154. doi: 10.4103/ijc.IJC_202_17.
3
RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.基于 RNA 的分析在免疫组化/荧光原位杂交结果不一致的非小细胞肺癌病例中检测 ALK 融合。
BMC Cancer. 2018 Nov 22;18(1):1158. doi: 10.1186/s12885-018-5070-6.
4
Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.晚期非小细胞肺癌患者恶性胸腔积液细胞块中ALK重排的检测:Ventana免疫组织化学与荧光原位杂交的比较
Cancer Cytopathol. 2015 Feb;123(2):117-22. doi: 10.1002/cncy.21510. Epub 2014 Dec 19.
5
Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.细胞学标本为福尔马林固定组织提供了一种有效的替代方法,新型自动化检测在肺腺癌的ALK断裂FISH检测和免疫组化中已证明了这一点。
Cancer Cytopathol. 2014 Nov;122(11):810-21. doi: 10.1002/cncy.21467. Epub 2014 Aug 5.
6
Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.非小细胞肺癌(NSCLC)中间变性淋巴瘤激酶(ALK)基因重排:多中心 ALK 检测结果。
Lung Cancer. 2013 Aug;81(2):200-6. doi: 10.1016/j.lungcan.2013.04.015. Epub 2013 May 10.
7
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.免疫组织化学检测非小细胞肺癌间变性淋巴瘤激酶重排:与荧光原位杂交的相关性。
J Thorac Oncol. 2011 Mar;6(3):466-72. doi: 10.1097/JTO.0b013e31820b82e8.
8
Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK-rearranged non-small cell lung cancer (NSCLC).比较四种不同的ALK抗体与手工免疫组织化学(IHC)用于筛查ALK重排的非小细胞肺癌(NSCLC)。
Lung Cancer. 2015 Dec;90(3):492-8. doi: 10.1016/j.lungcan.2015.10.002. Epub 2015 Oct 21.
9
Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.免疫组织化学是一种可靠的筛选工具,可用于鉴定非小细胞肺癌中的 ALK 重排,并且依赖于抗体。
J Thorac Oncol. 2013 Jan;8(1):45-51. doi: 10.1097/JTO.0b013e318274a83e.
10
Correlation of programmed death-ligand 1 expression with gene expression and clinicopathological parameters in Indian patients with non-small cell lung cancer.印度非小细胞肺癌患者程序性死亡配体1表达与基因表达及临床病理参数的相关性
Lung India. 2020 Mar-Apr;37(2):145-150. doi: 10.4103/lungindia.lungindia_488_19.

本文引用的文献

1
Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.晚期非小细胞肺癌(NSCLC)中ALK状态的荧光原位杂交(FISH)、免疫组化(IHC)和二代测序(NGS)分析结果的不一致性:7例简要报告
Transl Oncol. 2019 Feb;12(2):389-395. doi: 10.1016/j.tranon.2018.11.006. Epub 2018 Dec 4.
2
Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms.ALK 阳性非小细胞肺癌中的脑转移——是时候调整当前的治疗方案了。
Oncotarget. 2018 Oct 12;9(80):35181-35194. doi: 10.18632/oncotarget.26073.
3
ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients.ALK(D5F3)伴随诊断:一种用于识别ALK阳性非小细胞肺癌患者的免疫组织化学检测方法。
Pharmgenomics Pers Med. 2018 Sep 17;11:147-155. doi: 10.2147/PGPM.S156672. eCollection 2018.
4
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?非小细胞肺癌患者中ALK免疫组化和荧光原位杂交结果不一致与治疗反应:关于治疗与否问题的探讨
ESMO Open. 2018 Sep 17;3(6):e000419. doi: 10.1136/esmoopen-2018-000419. eCollection 2018.
5
Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.基于国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)肺癌腺癌分类的EML4-ALK、EGFR与临床病理特征之间的相关性
Medicine (Baltimore). 2018 Jun;97(26):e11116. doi: 10.1097/MD.0000000000011116.
6
Frequency of ALK Rearrangement by FISH Testing and its Correlation with ALK-IHC in Adenocarcinoma of Primary Lung Origin.原发性肺腺癌中通过荧光原位杂交(FISH)检测的ALK重排频率及其与ALK免疫组化的相关性
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1735-1738. doi: 10.22034/APJCP.2018.19.6.1735.
7
Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.肺癌中 ALK 和 ROS1 的生物标志物:免疫组织化学和荧光原位杂交。
Arch Pathol Lab Med. 2018 Aug;142(8):922-928. doi: 10.5858/arpa.2017-0502-RA. Epub 2018 Jun 14.
8
Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.非小细胞肺癌中PD-L1表达与驱动基因状态的关联:一项荟萃分析。
Oncotarget. 2018 Jan 5;9(7):7684-7699. doi: 10.18632/oncotarget.23969. eCollection 2018 Jan 26.
9
Regional reporting of the incidence of Anaplastic Lymphoma Kinase mutation in 379 non-small-cell lung cancer patients from Kolkata: Using immunohistochemistry as the diagnostic modality in a significant subset.加尔各答379例非小细胞肺癌患者间变性淋巴瘤激酶突变发生率的区域报告:在相当一部分患者中使用免疫组织化学作为诊断方法
South Asian J Cancer. 2017 Oct-Dec;6(4):169-170. doi: 10.4103/sajc.sajc_65_17.
10
Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.广泛多种肿瘤类型的融合对 ALK 靶向治疗有响应。
Oncologist. 2017 Dec;22(12):1444-1450. doi: 10.1634/theoncologist.2016-0488. Epub 2017 Oct 27.